Ho Tsoi

3.3k total citations · 2 hit papers
38 papers, 2.4k citations indexed

About

Ho Tsoi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ho Tsoi has authored 38 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Genetics. Recurrent topics in Ho Tsoi's work include Genetic Neurodegenerative Diseases (8 papers), Estrogen and related hormone effects (6 papers) and RNA Research and Splicing (6 papers). Ho Tsoi is often cited by papers focused on Genetic Neurodegenerative Diseases (8 papers), Estrogen and related hormone effects (6 papers) and RNA Research and Splicing (6 papers). Ho Tsoi collaborates with scholars based in Hong Kong, China and United States. Ho Tsoi's co-authors include Jun Yu, Joseph J.�Y. Sung, Ho Yin Edwin Chan, Geicho Nakatsu, Francis K.L. Chan, Siew C. Ng, Xiang Zhang, William Ka Kei Wu, Sunny H. Wong and Kunning Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Ho Tsoi

35 papers receiving 2.4k citations

Hit Papers

Gut mucosal microbiome across stages of colorectal carcin... 2015 2026 2018 2022 2015 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ho Tsoi Hong Kong 21 1.9k 616 379 349 247 38 2.4k
Liwei Dong China 35 1.6k 0.8× 440 0.7× 686 1.8× 425 1.2× 127 0.5× 102 3.2k
Heimo Strohmaier Austria 22 1.9k 1.0× 686 1.1× 781 2.1× 186 0.5× 88 0.4× 33 2.7k
Lily Huang United States 27 2.2k 1.2× 533 0.9× 278 0.7× 93 0.3× 136 0.6× 62 3.7k
Tathagat Dutta Ray United States 8 2.3k 1.2× 287 0.5× 789 2.1× 194 0.6× 231 0.9× 12 3.4k
Hui Xu China 24 1.9k 1.0× 179 0.3× 417 1.1× 242 0.7× 91 0.4× 88 3.0k
Juan Lin China 12 2.5k 1.3× 472 0.8× 413 1.1× 286 0.8× 53 0.2× 25 3.5k
Tzipora Goldkorn United States 34 2.1k 1.1× 425 0.7× 247 0.7× 208 0.6× 60 0.2× 54 3.0k
Hans A.R. Bluyssen Poland 33 1.2k 0.6× 927 1.5× 381 1.0× 204 0.6× 40 0.2× 72 2.8k
James E. Sligh United States 18 1.5k 0.8× 274 0.4× 185 0.5× 103 0.3× 131 0.5× 34 2.6k
Samuel G. Mackintosh United States 30 2.2k 1.1× 290 0.5× 210 0.6× 140 0.4× 61 0.2× 79 2.9k

Countries citing papers authored by Ho Tsoi

Since Specialization
Citations

This map shows the geographic impact of Ho Tsoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Tsoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Tsoi more than expected).

Fields of papers citing papers by Ho Tsoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Tsoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Tsoi. The network helps show where Ho Tsoi may publish in the future.

Co-authorship network of co-authors of Ho Tsoi

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Tsoi. A scholar is included among the top collaborators of Ho Tsoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Tsoi. Ho Tsoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsoi, Ho, Ellen P.S. Man, Ka Man Cheung, et al.. (2025). Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer. Journal of Translational Medicine. 23(1). 860–860.
2.
Khoo, US, et al.. (2024). 301 (PB289): BQ323636.1 modulates the AR-CDK20 axis to confer doxorubicin resistance in breast cancer. European Journal of Cancer. 211. 114815–114815.
3.
Tsoi, Ho, et al.. (2023). Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer. The Journal of Pathology. 261(2). 156–168. 2 indexed citations
4.
Tsoi, Ho, et al.. (2023). SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. Cancers. 15(8). 2271–2271. 1 indexed citations
6.
Gong, Chun, Ellen P.S. Man, Ho Tsoi, et al.. (2018). BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer. Clinical Cancer Research. 24(15). 3681–3691. 19 indexed citations
7.
Tsoi, Ho, Eagle SH Chu, Xiang Zhang, et al.. (2017). Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 152(6). 1419–1433.e5. 310 indexed citations
8.
Tsoi, Ho, Yu Dong, Xiaohu Zhang, et al.. (2017). Pre-45s rRNA promotes colon cancer and is associated with poor survival of CRC patients. Oncogene. 36(44). 6109–6118. 35 indexed citations
9.
Wong, Sunny H., Liuyang Zhao, Xiang Zhang, et al.. (2017). Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. Gastroenterology. 153(6). 1621–1633.e6. 464 indexed citations breakdown →
10.
Shen, Jiacheng, Ho Tsoi, Qiaoyi Liang, et al.. (2016). Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. Oncogene. 35(49). 6271–6280. 30 indexed citations
11.
Zhang, Jingwan, Ho Tsoi, Xiaoxing Li, et al.. (2015). Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis. Gut. 65(9). 1482–1493. 141 indexed citations
12.
Nakatsu, Geicho, Xiangchun Li, Haokui Zhou, et al.. (2015). Gut mucosal microbiome across stages of colorectal carcinogenesis. Nature Communications. 6(1). 8727–8727. 510 indexed citations breakdown →
13.
Wang, Kunning, Qiaoyi Liang, Xiaoxing Li, et al.. (2015). MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome. Gut. 65(10). 1619–1631. 58 indexed citations
14.
Tsoi, Ho, et al.. (2015). FusobacteriumandEscherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Review of Gastroenterology & Hepatology. 9(5). 651–657. 33 indexed citations
15.
Zhang, Lijing, Yujuan Dong, Ho Tsoi, et al.. (2014). microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Molecular Cancer. 13(1). 124–124. 113 indexed citations
16.
Tsoi, Ho & Ho Yin Edwin Chan. (2013). Roles of the nucleolus in the CAG RNA-mediated toxicity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(6). 779–784. 20 indexed citations
17.
Tsoi, Ho & Ho Yin Edwin Chan. (2013). Expression of Expanded CAG Transcripts Triggers Nucleolar Stress in Huntington's Disease. The Cerebellum. 12(3). 310–312. 57 indexed citations
18.
Tsoi, Ho, Terrence Chi‐Kong Lau, Suk Ying Tsang, Kwok‐Fai Lau, & Ho Yin Edwin Chan. (2012). CAG expansion induces nucleolar stress in polyglutamine diseases. Proceedings of the National Academy of Sciences. 109(33). 13428–13433. 112 indexed citations
19.
Tsoi, Ho, Terrence Chi‐Kong Lau, Kwok‐Fai Lau, & Ho Yin Edwin Chan. (2011). Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases. Human Molecular Genetics. 20(19). 3787–3797. 36 indexed citations
20.
Tsoi, Ho, Shenyu Zhai, Ching‐On Wong, et al.. (2009). The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function. The International Journal of Biochemistry & Cell Biology. 41(11). 2232–2239. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026